1994
DOI: 10.1007/bf00126741
|View full text |Cite
|
Sign up to set email alerts
|

Design of potential angiogenin inhibitors

Abstract: A model of angiogenin has been prepared by homology modelling, based upon the structure of ribonuclease A. This model has been used to postulate an inhibitor based upon the angiostatic agent TAN1120. The complex of ribonuclease A with a dinucleotide has been modelled and used as a guide to the binding orientation of daunomycin--the closest TAN1120 analogue for which the crystal structure and stereochemistry are available.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Our approach is supported by reports [40][41][42][43][44] phosphatase inhibitors [41], and angiogenin inhibitors [42] has been enabled through the use of virtual screening strategies.…”
Section: Accepted Manuscriptmentioning
confidence: 97%
“…Our approach is supported by reports [40][41][42][43][44] phosphatase inhibitors [41], and angiogenin inhibitors [42] has been enabled through the use of virtual screening strategies.…”
Section: Accepted Manuscriptmentioning
confidence: 97%